Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Stablecoin Development Corp (SDEV)

$1.15 -0.01 (-0.87%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	30.37M
Revenue (ttm)	0.00
Net Income (ttm)	-22.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	32,575
Avg Vol	954,946
Day's Range	N/A - N/A
Shares Out	27.12M
Stochastic %K	30%
Beta	0.20
Analysts	Strong Buy
Price Target	N/A

Company Profile

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoi...

Industry: Asset Management

Sector: Financial Services

Phone: 510 899 8800

Fax: 510 474 1577

Website: stabledev.com

Address:

2000 Powell Street, Suite 1150, EmeryVille, United States

Meril_Knoxville Jul. 28 at 11:43 PM

$TRUG $RDGT $PAPL $SDEV $SNOA

0 · Reply

demarco4ever Jul. 28 at 3:07 PM

$SDEV normally I tend to agree with you but this one is a BIG IF!

0 · Reply

topstockalerts Jul. 24 at 9:39 PM

$SDEV could get interesting fast if momentum builds

0 · Reply

Alshma1l Jul. 24 at 9:26 PM

$SDEV just hold

0 · Reply

demarco4ever Jul. 24 at 9:04 PM

$SDEV we are either & bottom or going down to 0

0 · Reply

demarco4ever Jul. 22 at 7:42 PM

$SDEV why is that. I’m trying to see why it’s worth the buy

0 · Reply

MasonRe1 Jul. 18 at 12:37 AM

$SDEV

0 · Reply

Alshma1l Jul. 17 at 9:38 PM

$SDEV I hope this announcement helps the stock rise.

1 · Reply

focafoca99 Jul. 17 at 8:37 PM

$SDEV promoted Henry Blynn to chief operating officer, effective July 15, with a $300K salary and RSU grant.

0 · Reply

Fede_Tech Jul. 16 at 3:50 PM

$SDEV nice green candle!

0 · Reply

SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders

May 20, 2026, 8:30 AM EDT - 2 months ago

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

May 20, 2026, 8:30 AM EDT - 2 months ago

Stablecoin Development Quarterly report: Q1 2026

May 20, 2026, 8:30 AM EDT - 2 months ago

Stablecoin Development Earnings release: Q1 2026

Apr 6, 2026, 8:30 AM EDT - 4 months ago

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”

Mar 23, 2026, 8:30 AM EDT - 4 months ago

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Mar 19, 2026, 7:00 AM EDT - 4 months ago

Stablecoin Development Annual report: Q4 2025

Mar 12, 2026, 2:00 PM EDT - 4 months ago

Stablecoin Development Transcript: EGM 2026

Mar 2, 2026, 7:00 AM EST - 5 months ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 10, 2026, 7:00 AM EST - 6 months ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 30, 2026, 7:00 AM EST - 6 months ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 8 months ago

Stablecoin Development Registration statement: Registration Filing

Nov 7, 2025, 4:00 PM EST - 9 months ago

Stablecoin Development Quarterly report: Q3 2025

Oct 20, 2025, 7:07 PM EDT - 10 months ago

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

Oct 9, 2025, 8:00 AM EDT - 10 months ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 10 months ago

Stablecoin Development Registration statement: Registration Filing

Sep 23, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 18, 2025, 4:30 PM EDT - 11 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Sep 18, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 10, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 26, 2025, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 1 year ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Stablecoin Development Quarterly report: Q2 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q1 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Annual report: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Feb 18, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 23, 2025, 8:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Jan 23, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 19, 2024, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 18, 2024, 2:00 PM EST - 1 year ago

Stablecoin Development Transcript: EGM 2024

Dec 11, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 6:50 AM EST - 1 year ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 26, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 22, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 1 year ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 15, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 13, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 7, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:00 PM EST - 1 year ago

Stablecoin Development Quarterly report: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Nov 6, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 20, 2024, 8:30 AM EDT - 2 years ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Sep 20, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 13, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q2 2024

Aug 13, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q2 2024

Aug 13, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 16, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 11, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 21, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 7, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 2 years ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 17, 2024, 6:59 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Annual report: Q4 2023

Mar 26, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Earnings Call Transcript: Q3 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Quarterly report: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 3 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 3 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 3 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 3 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Meril_Knoxville Jul. 28 at 11:43 PM

$TRUG $RDGT $PAPL $SDEV $SNOA

0 · Reply

demarco4ever Jul. 28 at 3:07 PM

$SDEV normally I tend to agree with you but this one is a BIG IF!

0 · Reply

topstockalerts Jul. 24 at 9:39 PM

$SDEV could get interesting fast if momentum builds

0 · Reply

Alshma1l Jul. 24 at 9:26 PM

$SDEV just hold

0 · Reply

demarco4ever Jul. 24 at 9:04 PM

$SDEV we are either & bottom or going down to 0

0 · Reply

demarco4ever Jul. 22 at 7:42 PM

$SDEV why is that. I’m trying to see why it’s worth the buy

0 · Reply

MasonRe1 Jul. 18 at 12:37 AM

$SDEV

0 · Reply

Alshma1l Jul. 17 at 9:38 PM

$SDEV I hope this announcement helps the stock rise.

1 · Reply

focafoca99 Jul. 17 at 8:37 PM

$SDEV promoted Henry Blynn to chief operating officer, effective July 15, with a $300K salary and RSU grant.

0 · Reply

Fede_Tech Jul. 16 at 3:50 PM

$SDEV nice green candle!

0 · Reply

Alshma1l Jul. 15 at 4:43 PM

$SDEV There is stock accumulation

0 · Reply

Fede_Tech Jul. 15 at 1:01 PM

$SDEV SKYUSD going up now! It will impact SDEV for good.

0 · Reply

BULLETSTOCK Jul. 13 at 9:43 PM

$VMAR + $SDEV ??????

0 · Reply

Alshma1l Jul. 13 at 7:23 PM

$SDEV support 1.16-1.11-1.04

1 · Reply

Alshma1l Jul. 10 at 12:07 PM

$SDEV No matter how much you learn stock analysis, this stock contradicts that analysis.

0 · Reply

Zardiw Jul. 9 at 2:38 PM

Found $JLHL on a DDAmanda scan this morning. Sharing the chart. Also found: $BIYA $NVVE $SDEV More on the scanner: https://DDAmanda.com

0 · Reply

Zardiw Jul. 9 at 1:24 PM

$LGHL: unusual activity detected. Also found early: $IOTR $BIYA $SDEV Full scanner: https://DDAmanda.com

0 · Reply

hardrock2112 Jul. 9 at 1:09 PM

$SDEV keeping an eye on this for break above 1.65

0 · Reply

Alshma1l Jul. 9 at 5:45 AM

$SDEV i hope today go to up 2+

0 · Reply

topstockalerts Jul. 8 at 8:44 PM

$SDEV the action is smooth enough to raise eyebrows.

0 · Reply

giglio75 Jul. 8 at 7:20 PM

$SDEV 🗯

0 · Reply

1.0.0